The same strategy could be applied to translational research: the next experimental medicine studies of statins ought to focus on samples of patients with depression or at-risk of depressive episodes, possibly pre-selected for high CRP, to elucidate whether our results are replicated or indeed reversed in these specific clinical samples. The gene discussed is CRP; the disease is major depressive disorder.